닥플 플러스
2026 대한조혈모세포이식학회 국제학술대회(ICBMT 2026) - 9월 19일(3일차)
대한조혈모세포이식학회
연수평점 :2점
오프라인
주관
대한조혈모세포이식학회
교육일자
2026-09-19
수강료
200,000원
교육형태
오프라인
등록일시
2026-07-29
교육시간
7시간 30분
연수평점
2점
장소
부산광역시 벡스코
교육종류
내과, 소아청소년과, 진단검사의학과
타임테이블
| 날짜 | 시간 | 강의명 | 강사 | 구분 |
|---|---|---|---|---|
| 2026-09-19 | 08:30~09:00 | Ph-positive ALL in 2026: From Precision Immuno-targeted Therapy to Transplantation | Jae-Ho Yoon(College of Medicine, The Catholic University of Korea) | - |
| 2026-09-19 | 09:00~09:30 | Hepatic, Pulmonary, and Systemic Endothelial Injury after Allogeneic HSCT: SOS/VOD, Capillary Leak/Engraftment Syndrome, and IPS/DAH | Hakan Göker(Hacettepe University) | - |
| 2026-09-19 | 09:30~10:00 | Microvascular and CNS Endothelial Dysfunction (TA-TMA, PRES, GVHD-Related Endothelial Injury) | Suhyun Yoon(Korea University College of Medicine) | - |
| 2026-09-19 | 09:00~09:10 | [구연발표]Longitudinal Immune Reconstitution and Viral Landscape Under Letermovir Prophylaxis in Pediatric Allogeneic HSCT | Qingwei Wang(Childrens Hospital of Soochow University) | - |
| 2026-09-19 | 09:10~09:20 | [구연발표]Outcomes of ex vivo T cell depleted haploidentical HSCT in children with acute lymphoblastic leukemia | Sung Han Kang(Asan Medical Center Childrens Hospital, University of Ulsan College of Medicine) | - |
| 2026-09-19 | 09:20~09:30 | [구연발표]Comparative Outcomes of Carboplatin-Etoposide-Melphalan and Busulfan-Melphalan as High-Dose Chemotherapy for High-Risk Neuroblastoma: An International Two-Center Study from Taiwan and Korea | Jin Kyung Suh(Asan Medical Center Children) | - |
| 2026-09-19 | 09:30~09:40 | [구연발표]Real-World Outcomes Of Chimeric Antigen Receptor T-Cell Therapy In Pediatric B-Cell Acute Lymphoblastic Leukemia: Role Of Consolidative Hematopoietic Cell Transplantation | Jae Won Yoo(Seoul St. Marys Hospital, College of Medicine, The Catholic University of Korea) | - |
| 2026-09-19 | 09:40~09:50 | [구연발표]Haploidentical Transplantation with Unrelated Cord Blood Support (SZ-19-TM Protocol) Improves Outcomes in Pediatric Transfusion-Dependent Thalassemia: A Large-Scale Retrospective Cohort Study | Ruihao Zheng(Shenzhen Childrens Hospital) | - |
| 2026-09-19 | 09:50~10:00 | [구연발표]Pre-freezing Hematocrit Independently Associated with Post-thaw CD34+ Cell Viability in Cryopreserved Autologous Peripheral Blood Stem Cell Products from Pediatric Neuroblastoma Patients | Thi Thanh Lam Nguyen(National Childrens hospital) | - |
| 2026-09-19 | 09:00~09:10 | [구연발표]Single-Cell Transcriptomic and TCR Repertoire Profiling Defines an Exhaustion-Associated CD39+ CD8+ T-Cell State in the Bone Marrow of Acute Lymphoblastic Leukemia | Nayeon Seong(The Catholic University of Korea, Ajou University School of Medicine) | - |
| 2026-09-19 | 09:10~09:20 | [구연발표]Assessment of CRS-Related Toxicity of BCMA CAR-MILs Using the NSG-SGM3 Model | Manh Cuong Vo(Chonnam National University Hwasun Hospital, Vaxcell-Bio) | - |
| 2026-09-19 | 09:20~09:30 | [구연발표]First Korean Report of Donor-Derived Multivirus-Specific T-Cell Therapy for Refractory BK Virus Hemorrhagic Cystitis after Pediatric Haploidentical Hematopoietic Cell Transplantation | Jae Won Yoo(Seoul St. Marys Hospital, College of Medicine, The Catholic University of Korea) | - |
| 2026-09-19 | 09:30~09:40 | [구연발표]Development of Bispecific CAR- T Cells Targeting Mesothelin (MSLN) and Disialoganglioside 2 (GD2) for Neuroblastoma | Nayoung Kim(Asan Medical Center) | - |
| 2026-09-19 | 09:40~09:50 | [구연발표]First-in-Human Phase 1 Study of GF-CART01, a Non-Viral CD19/CD20 Dual-Targeting CAR T Generated Using the qCART Platform in Relapsed/Refractory B-Cell Malignancies | Shang-Ju Wu(National Taiwan University Hospital) | - |
| 2026-09-19 | 09:50~10:00 | [구연발표]Exploring the Therapeutic Potential of CAR-MSCs Targeting the OX40/OX40L Axis in Immune Disorders | Byungchan Kim(Samsung Medical Center, Sungkyunkwan University) | - |
| 2026-09-19 | 10:00~10:10 | 휴식 | - | - |
| 2026-09-19 | 10:10~10:40 | Pediatric Chronic GVHD: From Biological Insights to Clinical Management | Kirk Schultz(BC Childrens Hospital Research Insitutue) | - |
| 2026-09-19 | 10:40~11:10 | Immunobiology of GVHD Prevention | Takanori Teshima(Hokkaido University) | - |
| 2026-09-19 | 11:10~11:40 | Microbiome and GvHD Following Allogeneic HSCT | Yoo Jin Lee(University of Ulsan College of Medicine) | - |
| 2026-09-19 | 10:10~10:40 | Integrating MRD into CAR T-cell Therapy for ALL: from Patient Selection to Post-treatment Intervention | Jae Park(Memorial Sloan Kettering Cancer Center) | - |
| 2026-09-19 | 10:40~11:10 | Sequencing Cellular Therapy in Multiple Myeloma: Lessons from Trials and Real-world Practice | Binod Dhakal(Medical College of Wisconsin) | - |
| 2026-09-19 | 11:10~11:40 | Real-world CAR‑T Experience in LBCL | Young Woo Jeon(The Catholic University of Korea) | - |
| 2026-09-19 | 10:10~10:40 | Radiotherapy in Hematologic Malignancies and Stem Cell Transplantation | Yang-Gun Suh(National Cancer Center) | - |
| 2026-09-19 | 10:40~11:10 | Restoring Normal life for Hematology Patients | Kwang-Sung Kim(College of Medicine, The Catholic University of Korea) | - |
비고
회원 150,000원, 비회원 200,000원, 기타 80,000원
문의처
담당자
김혜진
연락처
02-516-6581
이메일
bmt@kams.or.kr